Feedback / Questions
dusigitumab (MEDI-573) - AstraZeneca
AstraZeneca: ASCO 2014 Meeting
(AstraZeneca)
-
Jun 8, 2014 -
Anticipated regulatory submission for metastatic breast cancer after 2017
Anticipated regulatory
•
Breast Cancer • Oncology
http://www.astrazeneca.com/cs/Satellite?blobcol=urldata&blobheader=application%2Fpdf&blobheadername1=Content-Disposition&blobheadername2=MDT-Type&blobheadervalue1=inline%3B+filename%3DDownload-presentation.pdf&blobheadervalue2=abinary%3B+charset%3DUTF-8&blobkey=id&blobtable=MungoBlobs&blobwhere=1285673317058&ssbinary=true
Jun 8, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious